Mofezolac

DB21153ExperimentalSmall molecule

Mofezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Mofezolac is a anti-inflammatory agent, ibufenac derivative. Mofezolac has a monoisotopic molecular...

Mechanism: Pharmacologically active on Prostaglandin G/H synthase 1
Curator reviewed
Formula / weight: C₁₉H₁₇NO₅ · 339.347 g/mol (avg)

Resolves to

Compound

UNIIRVJ0BV3H3YCAS78967-07-4ChEMBLCHEMBL259972ChEBI31860PubChem4237

Clinical / RWD

RxNorm11469

Structure

InChIKeyDJEIHHYCDCTAAH-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1)C1=NOC(CC(O)=O)=C1C1=CC=C(OC)C=C1

Targets

P23219PTGS1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mofezolac, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account